Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J B van Ommen

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Inherited Metabolic Disease|July 26, 2002
The Human Genome Project and the future of diagnostics, treatment and preventionG J B van Ommen
Biotechniques|November 27, 2002
Interruption of perfect CAG repeats by CAA triplets improves the stability of glutamine-encoding repeat sequencesJ C Dorsman, M Bremmer-Bout, B Pepers, et al.
Journal of Medical Genetics|October 22, 2003
An alternative to FISH: detecting deletion and duplication carriers within 24 hoursS J White, E Sterrenburg, G-J B van Ommen, et al.
Nucleic Acids Research|February 22, 2003
Fluorescent labelling of cRNA for microarray applicationsPeter A C 't Hoen, Floor de Kort, G J B van Ommen, et al.
Journal of Medical Genetics|November 5, 2002
Behavioural complaints in participants who underwent predictive testing for Huntington's diseaseM-N W Witjes-Ané, A H Zwinderman, A Tibben, et al.
BMC Genomics|July 14, 2005
Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profilingR Turk, E Sterrenburg, E J de Meijer, et al.
Journal of Inherited Metabolic Disease|January 26, 2006
Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotypeG de Voer, P van der Bent, A J G Rodrigues, et al.
Annals of the New York Academy of Sciences|December 6, 2006
Therapeutic modulation of DMD splicing by blocking exonic splicing enhancer sites with antisense oligonucleotidesA Aartsma-Rus, A A M Janson, J A Heemskerk, et al.
Neurology|September 25, 2009
Normal and mutant HTT interact to affect clinical severity and progression in Huntington diseaseN A Aziz, C K Jurgens, G B Landwehrmeyer, et al.
Gene Therapy|July 2, 2004
Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cellsA Aartsma-Rus, W E Kaman, M Bremmer-Bout, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Inherited Metabolic Disease|July 26, 2002
The Human Genome Project and the future of diagnostics, treatment and preventionG J B van Ommen
Biotechniques|November 27, 2002
Interruption of perfect CAG repeats by CAA triplets improves the stability of glutamine-encoding repeat sequencesJ C Dorsman, M Bremmer-Bout, B Pepers, et al.
Journal of Medical Genetics|October 22, 2003
An alternative to FISH: detecting deletion and duplication carriers within 24 hoursS J White, E Sterrenburg, G-J B van Ommen, et al.
Nucleic Acids Research|February 22, 2003
Fluorescent labelling of cRNA for microarray applicationsPeter A C 't Hoen, Floor de Kort, G J B van Ommen, et al.
Journal of Medical Genetics|November 5, 2002
Behavioural complaints in participants who underwent predictive testing for Huntington's diseaseM-N W Witjes-Ané, A H Zwinderman, A Tibben, et al.
BMC Genomics|July 14, 2005
Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profilingR Turk, E Sterrenburg, E J de Meijer, et al.
Journal of Inherited Metabolic Disease|January 26, 2006
Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotypeG de Voer, P van der Bent, A J G Rodrigues, et al.
Annals of the New York Academy of Sciences|December 6, 2006
Therapeutic modulation of DMD splicing by blocking exonic splicing enhancer sites with antisense oligonucleotidesA Aartsma-Rus, A A M Janson, J A Heemskerk, et al.
Neurology|September 25, 2009
Normal and mutant HTT interact to affect clinical severity and progression in Huntington diseaseN A Aziz, C K Jurgens, G B Landwehrmeyer, et al.
Gene Therapy|July 2, 2004
Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cellsA Aartsma-Rus, W E Kaman, M Bremmer-Bout, et al.
Pageof 2